Also called: cellular therapy
UAMS is the first and only hospital in Arkansas approved to provide a revolutionary new therapy for certain types of non-Hodgkin lymphoma.
Chimeric antigen receptor (CAR) T-cell therapy uses new technology to genetically modify a patient’s own T cells, enabling them to seek and destroy cancer cells. T cells are a type of white blood cell integral to the immune system.